Global Blood Cancer Molecular Diagnostics Market Growth (Status and Outlook) 2026-2032

May 2026 | 113 pages | ID: G7412EE534ADEN
LP Information

Abstracts

The global Blood Cancer Molecular Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Blood Cancer Molecular Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Blood Cancer Molecular Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Blood Cancer Molecular Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Blood Cancer Molecular Diagnostics players cover Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Blood Cancer Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world Blood Cancer Molecular Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Cancer Molecular Diagnostics sales for 2026 through 2032. With Blood Cancer Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Cancer Molecular Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Blood Cancer Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood Cancer Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Cancer Molecular Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Cancer Molecular Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Cancer Molecular Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Cancer Molecular Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Polymerase Chain Reaction
• Molecular Hybridization
• Biochip
• Others

Segmentation by Application:

• Hospital
• Third-Party Testing Agency
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche Diagnostics
• Abbott
• Thermo Fisher
• Qiagen
• Illumina
• Agilent
• Liferiver
• Gpmedical
• Zeesan
• Berry Oncology
• Annoroad

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Blood Cancer Molecular Diagnostics Market Size (2021-2032)
  2.1.2 Blood Cancer Molecular Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Blood Cancer Molecular Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Blood Cancer Molecular Diagnostics Segment by Type
  2.2.1 Polymerase Chain Reaction
  2.2.2 Molecular Hybridization
  2.2.3 Biochip
  2.2.4 Others
  2.2.5 Blood Cancer Molecular Diagnostics Market Size by Type
    2.2.5.1 Blood Cancer Molecular Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global Blood Cancer Molecular Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Blood Cancer Molecular Diagnostics Segment by Application
  2.3.1 Hospital
  2.3.2 Third-Party Testing Agency
  2.3.3 Others
  2.3.4 Blood Cancer Molecular Diagnostics Market Size by Application
    2.3.4.1 Blood Cancer Molecular Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Blood Cancer Molecular Diagnostics Market Size Market Share by Application (2021-2026)

3 BLOOD CANCER MOLECULAR DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Blood Cancer Molecular Diagnostics Market Size Market Share by Player
  3.1.1 Global Blood Cancer Molecular Diagnostics Revenue by Player (2021-2026)
  3.1.2 Global Blood Cancer Molecular Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Blood Cancer Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BLOOD CANCER MOLECULAR DIAGNOSTICS BY REGION

4.1 Blood Cancer Molecular Diagnostics Market Size by Region (2021-2026)
4.2 Global Blood Cancer Molecular Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood Cancer Molecular Diagnostics Market Size Growth (2021-2026)
4.4 APAC Blood Cancer Molecular Diagnostics Market Size Growth (2021-2026)
4.5 Europe Blood Cancer Molecular Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Blood Cancer Molecular Diagnostics Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Blood Cancer Molecular Diagnostics Market Size by Country (2021-2026)
5.2 Americas Blood Cancer Molecular Diagnostics Market Size by Type (2021-2026)
5.3 Americas Blood Cancer Molecular Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Blood Cancer Molecular Diagnostics Market Size by Region (2021-2026)
6.2 APAC Blood Cancer Molecular Diagnostics Market Size by Type (2021-2026)
6.3 APAC Blood Cancer Molecular Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Blood Cancer Molecular Diagnostics Market Size by Country (2021-2026)
7.2 Europe Blood Cancer Molecular Diagnostics Market Size by Type (2021-2026)
7.3 Europe Blood Cancer Molecular Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Blood Cancer Molecular Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Blood Cancer Molecular Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Blood Cancer Molecular Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BLOOD CANCER MOLECULAR DIAGNOSTICS MARKET FORECAST

10.1 Global Blood Cancer Molecular Diagnostics Forecast by Region (2027-2032)
  10.1.1 Global Blood Cancer Molecular Diagnostics Forecast by Region (2027-2032)
  10.1.2 Americas Blood Cancer Molecular Diagnostics Forecast
  10.1.3 APAC Blood Cancer Molecular Diagnostics Forecast
  10.1.4 Europe Blood Cancer Molecular Diagnostics Forecast
  10.1.5 Middle East & Africa Blood Cancer Molecular Diagnostics Forecast
10.2 Americas Blood Cancer Molecular Diagnostics Forecast by Country (2027-2032)
  10.2.1 United States Market Blood Cancer Molecular Diagnostics Forecast
  10.2.2 Canada Market Blood Cancer Molecular Diagnostics Forecast
  10.2.3 Mexico Market Blood Cancer Molecular Diagnostics Forecast
  10.2.4 Brazil Market Blood Cancer Molecular Diagnostics Forecast
10.3 APAC Blood Cancer Molecular Diagnostics Forecast by Region (2027-2032)
  10.3.1 China Blood Cancer Molecular Diagnostics Market Forecast
  10.3.2 Japan Market Blood Cancer Molecular Diagnostics Forecast
  10.3.3 Korea Market Blood Cancer Molecular Diagnostics Forecast
  10.3.4 Southeast Asia Market Blood Cancer Molecular Diagnostics Forecast
  10.3.5 India Market Blood Cancer Molecular Diagnostics Forecast
  10.3.6 Australia Market Blood Cancer Molecular Diagnostics Forecast
10.4 Europe Blood Cancer Molecular Diagnostics Forecast by Country (2027-2032)
  10.4.1 Germany Market Blood Cancer Molecular Diagnostics Forecast
  10.4.2 France Market Blood Cancer Molecular Diagnostics Forecast
  10.4.3 UK Market Blood Cancer Molecular Diagnostics Forecast
  10.4.4 Italy Market Blood Cancer Molecular Diagnostics Forecast
  10.4.5 Russia Market Blood Cancer Molecular Diagnostics Forecast
10.5 Middle East & Africa Blood Cancer Molecular Diagnostics Forecast by Region (2027-2032)
  10.5.1 Egypt Market Blood Cancer Molecular Diagnostics Forecast
  10.5.2 South Africa Market Blood Cancer Molecular Diagnostics Forecast
  10.5.3 Israel Market Blood Cancer Molecular Diagnostics Forecast
  10.5.4 Turkey Market Blood Cancer Molecular Diagnostics Forecast
10.6 Global Blood Cancer Molecular Diagnostics Forecast by Type (2027-2032)
10.7 Global Blood Cancer Molecular Diagnostics Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Blood Cancer Molecular Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche Diagnostics
  11.1.1 Roche Diagnostics Company Information
  11.1.2 Roche Diagnostics Blood Cancer Molecular Diagnostics Product Offered
  11.1.3 Roche Diagnostics Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Roche Diagnostics Main Business Overview
  11.1.5 Roche Diagnostics Latest Developments
11.2 Abbott
  11.2.1 Abbott Company Information
  11.2.2 Abbott Blood Cancer Molecular Diagnostics Product Offered
  11.2.3 Abbott Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Abbott Main Business Overview
  11.2.5 Abbott Latest Developments
11.3 Thermo Fisher
  11.3.1 Thermo Fisher Company Information
  11.3.2 Thermo Fisher Blood Cancer Molecular Diagnostics Product Offered
  11.3.3 Thermo Fisher Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Thermo Fisher Main Business Overview
  11.3.5 Thermo Fisher Latest Developments
11.4 Qiagen
  11.4.1 Qiagen Company Information
  11.4.2 Qiagen Blood Cancer Molecular Diagnostics Product Offered
  11.4.3 Qiagen Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Qiagen Main Business Overview
  11.4.5 Qiagen Latest Developments
11.5 Illumina
  11.5.1 Illumina Company Information
  11.5.2 Illumina Blood Cancer Molecular Diagnostics Product Offered
  11.5.3 Illumina Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Illumina Main Business Overview
  11.5.5 Illumina Latest Developments
11.6 Agilent
  11.6.1 Agilent Company Information
  11.6.2 Agilent Blood Cancer Molecular Diagnostics Product Offered
  11.6.3 Agilent Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Agilent Main Business Overview
  11.6.5 Agilent Latest Developments
11.7 Liferiver
  11.7.1 Liferiver Company Information
  11.7.2 Liferiver Blood Cancer Molecular Diagnostics Product Offered
  11.7.3 Liferiver Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Liferiver Main Business Overview
  11.7.5 Liferiver Latest Developments
11.8 Gpmedical
  11.8.1 Gpmedical Company Information
  11.8.2 Gpmedical Blood Cancer Molecular Diagnostics Product Offered
  11.8.3 Gpmedical Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Gpmedical Main Business Overview
  11.8.5 Gpmedical Latest Developments
11.9 Zeesan
  11.9.1 Zeesan Company Information
  11.9.2 Zeesan Blood Cancer Molecular Diagnostics Product Offered
  11.9.3 Zeesan Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Zeesan Main Business Overview
  11.9.5 Zeesan Latest Developments
11.10 Berry Oncology
  11.10.1 Berry Oncology Company Information
  11.10.2 Berry Oncology Blood Cancer Molecular Diagnostics Product Offered
  11.10.3 Berry Oncology Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Berry Oncology Main Business Overview
  11.10.5 Berry Oncology Latest Developments
11.11 Annoroad
  11.11.1 Annoroad Company Information
  11.11.2 Annoroad Blood Cancer Molecular Diagnostics Product Offered
  11.11.3 Annoroad Blood Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Annoroad Main Business Overview
  11.11.5 Annoroad Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Blood Cancer Molecular Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Blood Cancer Molecular Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Polymerase Chain Reaction
Table 4. Major Players of Molecular Hybridization
Table 5. Major Players of Biochip
Table 6. Major Players of Others
Table 7. Blood Cancer Molecular Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Blood Cancer Molecular Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Blood Cancer Molecular Diagnostics Market Size Market Share by Type (2021-2026)
Table 10. Blood Cancer Molecular Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Blood Cancer Molecular Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Blood Cancer Molecular Diagnostics Market Size Market Share by Application (2021-2026)
Table 13. Global Blood Cancer Molecular Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Blood Cancer Molecular Diagnostics Revenue Market Share by Player (2021-2026)
Table 15. Blood Cancer Molecular Diagnostics Key Players Head office and Products Offered
Table 16. Blood Cancer Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Blood Cancer Molecular Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Blood Cancer Molecular Diagnostics Market Size Market Share by Region (2021-2026)
Table 21. Global Blood Cancer Molecular Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Blood Cancer Molecular Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Blood Cancer Molecular Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Blood Cancer Molecular Diagnostics Market Size Market Share by Country (2021-2026)
Table 25. Americas Blood Cancer Molecular Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Blood Cancer Molecular Diagnostics Market Size Market Share by Type (2021-2026)
Table 27. Americas Blood Cancer Molecular Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Blood Cancer Molecular Diagnostics Market Size Market Share by Application (2021-2026)
Table 29. APAC Blood Cancer Molecular Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Blood Cancer Molecular Diagnostics Market Size Market Share by Region (2021-2026)
Table 31. APAC Blood Cancer Molecular Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Blood Cancer Molecular Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Blood Cancer Molecular Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Blood Cancer Molecular Diagnostics Market Size Market Share by Country (2021-2026)
Table 35. Europe Blood Cancer Molecular Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Blood Cancer Molecular Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Blood Cancer Molecular Diagnostics
Table 41. Key Market Challenges & Risks of Blood Cancer Molecular Diagnostics
Table 42. Key Industry Trends of Blood Cancer Molecular Diagnostics
Table 43. Global Blood Cancer Molecular Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Blood Cancer Molecular Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Blood Cancer Molecular Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Blood Cancer Molecular Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Roche Diagnostics Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 48. Roche Diagnostics Blood Cancer Molecular Diagnostics Product Offered
Table 49. Roche Diagnostics Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Roche Diagnostics Main Business
Table 51. Roche Diagnostics Latest Developments
Table 52. Abbott Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 53. Abbott Blood Cancer Molecular Diagnostics Product Offered
Table 54. Abbott Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Abbott Main Business
Table 56. Abbott Latest Developments
Table 57. Thermo Fisher Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 58. Thermo Fisher Blood Cancer Molecular Diagnostics Product Offered
Table 59. Thermo Fisher Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Thermo Fisher Main Business
Table 61. Thermo Fisher Latest Developments
Table 62. Qiagen Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 63. Qiagen Blood Cancer Molecular Diagnostics Product Offered
Table 64. Qiagen Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Qiagen Main Business
Table 66. Qiagen Latest Developments
Table 67. Illumina Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 68. Illumina Blood Cancer Molecular Diagnostics Product Offered
Table 69. Illumina Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Illumina Main Business
Table 71. Illumina Latest Developments
Table 72. Agilent Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 73. Agilent Blood Cancer Molecular Diagnostics Product Offered
Table 74. Agilent Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Agilent Main Business
Table 76. Agilent Latest Developments
Table 77. Liferiver Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 78. Liferiver Blood Cancer Molecular Diagnostics Product Offered
Table 79. Liferiver Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Liferiver Main Business
Table 81. Liferiver Latest Developments
Table 82. Gpmedical Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 83. Gpmedical Blood Cancer Molecular Diagnostics Product Offered
Table 84. Gpmedical Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Gpmedical Main Business
Table 86. Gpmedical Latest Developments
Table 87. Zeesan Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 88. Zeesan Blood Cancer Molecular Diagnostics Product Offered
Table 89. Zeesan Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Zeesan Main Business
Table 91. Zeesan Latest Developments
Table 92. Berry Oncology Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 93. Berry Oncology Blood Cancer Molecular Diagnostics Product Offered
Table 94. Berry Oncology Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Berry Oncology Main Business
Table 96. Berry Oncology Latest Developments
Table 97. Annoroad Details, Company Type, Blood Cancer Molecular Diagnostics Area Served and Its Competitors
Table 98. Annoroad Blood Cancer Molecular Diagnostics Product Offered
Table 99. Annoroad Blood Cancer Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Annoroad Main Business
Table 101. Annoroad Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Blood Cancer Molecular Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood Cancer Molecular Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Blood Cancer Molecular Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Blood Cancer Molecular Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Blood Cancer Molecular Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Blood Cancer Molecular Diagnostics Market Size Market Share by Type in 2025
Figure 10. Blood Cancer Molecular Diagnostics in Hospital
Figure 11. Global Blood Cancer Molecular Diagnostics Market: Hospital (2021-2026) & ($ millions)
Figure 12. Blood Cancer Molecular Diagnostics in Third-Party Testing Agency
Figure 13. Global Blood Cancer Molecular Diagnostics Market: Third-Party Testing Agency (2021-2026) & ($ millions)
Figure 14. Blood Cancer Molecular Diagnostics in Others
Figure 15. Global Blood Cancer Molecular Diagnostics Market: Others (2021-2026) & ($ millions)
Figure 16. Global Blood Cancer Molecular Diagnostics Market Size Market Share by Application in 2025
Figure 17. Global Blood Cancer Molecular Diagnostics Revenue Market Share by Player in 2025
Figure 18. Global Blood Cancer Molecular Diagnostics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Blood Cancer Molecular Diagnostics Market Size 2021-2026 ($ millions)
Figure 20. APAC Blood Cancer Molecular Diagnostics Market Size 2021-2026 ($ millions)
Figure 21. Europe Blood Cancer Molecular Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Americas Blood Cancer Molecular Diagnostics Value Market Share by Country in 2025
Figure 24. United States Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Blood Cancer Molecular Diagnostics Market Size Market Share by Region in 2025
Figure 29. APAC Blood Cancer Molecular Diagnostics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Blood Cancer Molecular Diagnostics Market Size Market Share by Application (2021-2026)
Figure 31. China Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Blood Cancer Molecular Diagnostics Market Size Market Share by Country in 2025
Figure 38. Europe Blood Cancer Molecular Diagnostics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Blood Cancer Molecular Diagnostics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Blood Cancer Molecular Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 54. APAC Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 55. Europe Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. United States Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Canada Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. China Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Japan Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. Korea Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. India Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Australia Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. Germany Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. France Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. UK Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Italy Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. Russia Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Israel Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Global Blood Cancer Molecular Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Blood Cancer Molecular Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Blood Cancer Molecular Diagnostics Market Size 2027-2032 ($ millions)